Log in

CNSX:VRT - Veritas Pharma Stock Price, Forecast & News

Today's Range N/A
50-Day Range
$0.22
MA: $0.28
$0.42
52-Week Range N/A
Volume2,475 shs
Average Volume73,073 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Veritas Pharma Inc. focuses on the development of proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VRT News and Ratings via Email

Sign-up to receive the latest news and ratings for VRT and its competitors with MarketBeat's FREE daily newsletter.


Veritas Pharma (CNSX:VRT) Frequently Asked Questions

What is Veritas Pharma's stock symbol?

Veritas Pharma trades on the CNSX under the ticker symbol "VRT."

Has Veritas Pharma been receiving favorable news coverage?

News stories about VRT stock have been trending extremely negative on Thursday, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Veritas Pharma earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Veritas Pharma.

Who are some of Veritas Pharma's key competitors?

What other stocks do shareholders of Veritas Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veritas Pharma investors own include Surna (SRNA), CannTrust (CTST), Aurora Cannabis (ACBFF), MedReleaf (LEAF), Abattis Bioceuticals (ATT), Adobe (ADBE), Erie Indemnity (ERIE), EXACT Sciences (EXAS), IDEXX Laboratories (IDXX) and Kinsale Capital Group (KNSL).

Who are Veritas Pharma's key executives?

Veritas Pharma's management team includes the folowing people:
  • Mr. Peter McFadden, Interim Pres, CEO & CFO
  • Ms. Barbara J. Joe, Controller
  • Mr. Blair C. Lowther, Corp. Sec. & Director

How do I buy shares of Veritas Pharma?

Shares of VRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Veritas Pharma's official website?

The official website for Veritas Pharma is http://www.veritaspharmainc.com/.


MarketBeat Community Rating for Veritas Pharma (CNSX VRT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about Veritas Pharma and other stocks. Vote "Outperform" if you believe VRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel